Effects of tiotropium/olodaterol on activity-related breathlessness, exercise endurance and physical activity in patients with COPD: narrative review with meta-/pooled …

F Maltais, A de la Hoz, R Casaburi, D O'Donnell - Advances in Therapy, 2021 - Springer
… optimisation by means of dual bronchodilation with tiotropium/olodaterol, and present new
data … We also examine the relationship between reducing activity-related breathlessness, the …

Targeting exertional breathlessness to improve physical activity: the role of primary care

M Román-Rodríguez, JWH Kocks - NPJ Primary Care Respiratory …, 2021 - nature.com
… that addresses activity-related breathlessness can help … Umeclidinium/vilanterol has
been shown to reduce breathlessness … Furthermore, dual bronchodilation with tiotropium/olodaterol

Assessment of physical functioning in patients with chronic obstructive pulmonary disease (COPD) requiring long-acting dual bronchodilation in routine clinical …

JM París, PMA Hernández, JAD García… - Medicina de Familia …, 2021 - Elsevier
Breathlessness and COPD-associated symptoms cause patients to reduce PA, leading to a
… the FDC of tiotropium/olodaterol would be those patients with lower physical functioning at …

Reducing and managing chronic obstructive pulmonary disease exacerbations with tiotropium+ olodaterol

G Criner, S Duffy - Current Medical Research and Opinion, 2021 - Taylor & Francis
… disease exacerbations with tiotropium + olodaterol … and include mono-bronchodilation or
dual bronchodilation (short- and … time and reduced physical activityrelated dyspnea with or …

Physical functioning in patients with chronic obstructive pulmonary disease treated with tiotropium/olodaterol Respimat in routine clinical practice in Italy

M Carone, A Pennisi, M D'Amato, AF Donati, A Ricci… - Pulmonary …, 2020 - Springer
… Moreover, a lower level of physical activity has the strongest … -acting dual bronchodilation
(LAMA + LABA) treatment with … based on the modified Medical Research Council dyspnea

Efficacy of tiotropium/olodaterol compared with tiotropium as a first-line maintenance treatment in patients with COPD who are naïve to LAMA, LABA and ICS: pooled …

R Buhl, A de la Hoz, W Xue, D Singh, GT Ferguson - Advances in Therapy, 2020 - Springer
… (lower limit FEV … dyspnoea severity compared with tiotropium alone, without compromising
patient safety. These results support the use of dual bronchodilation with tiotropium/olodaterol

[HTML][HTML] The effect of dual bronchodilatory therapy on the clinical control of chronic obstructive pulmonary disease in real clinical practice

NV Trushenko, SN Avdeev, GS Nuralieva… - …, 2021 - journal.pulmonology.ru
… 40 years who were prescribed tiotropium/olodaterol 5/5 μg via … condition, the severity of
dyspnea according to the mMRC … to a decrease in the number of CCQ points by more than 0.4 …

Pharmacotherapy of LAMA/LABA inhaled therapy combinations for chronic obstructive pulmonary disease: a clinical overview

MG Matera, B Rinaldi, C Belardo… - Expert Review of Clinical …, 2022 - Taylor & Francis
Dual bronchodilator reduced activity-related dyspnea, as judged by the … tiotropium/olodaterol
versus tiotropium to achieve a clinically significant improvement in activity-related dyspnea

Exercise capacity and physical activity in COPD patients treated with a LAMA/LABA combination: a systematic review and meta-analysis

M Miravitlles, JL García-Rivero, X Ribera, J Galera… - Respiratory …, 2022 - Springer
… Persistent airflow limitation and dyspnoea may reduce … inactive patients and daily
activity-related energy expenditure, and … -analysis, where tiotropium/olodaterol was the most …

Future concepts in bronchodilation for COPD: dual-versus monotherapy

D Singh, JF Donohue, IH Boucot… - European …, 2021 - Eur Respiratory Soc
… such as activity-related breathlessness and inspiratory … treatment over monotherapy for
CID, further prospective studies … of dual bronchodilation can reduce the risk of future disease …